Autism Spectrum Disorder Diagnostics Forecast Report – Designed for Decision Makers and Product Teams
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Market Size of the Autism Spectrum Disorder Diagnostics Market In 2029?
In recent years, the market size for diagnosis of autism spectrum disorder has experienced solid growth. It is projected to expand from $27.39 billion in 2024 to $29.44 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. The historical period growth can be credited to elements such as increased awareness and identification of ASD, the broadening of diagnostic criteria, progress in diagnostic equipment, the enhancement of the healthcare system, and public health campaigns.
What Growth Rate Is Forecasted for the Autism Spectrum Disorder Diagnostics Market by 2029?
In the coming years, the autism spectrum disorder diagnostics market size is predicted to witness robust growth. The market is projected to reach $38.94 billion by 2029, registering a compound annual growth rate (CAGR) of 7.2%. This predicted growth during the forecast period is linked to rising occurrences of autism spectrum disorder, increased consciousness and preliminary screening programs, emphasis on precision medicine and biomarkers. Some key trends expected within the forecast period include the continuous development of inventive technologies, an emerging focus on adult diagnosis, growing demand for point-of-care testing, the incorporation of artificial intelligence (AI) and machine learning, as well as an increase in research activity.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16593&type=smp
Which Key Companies Are Shaping the Future of the Autism Spectrum Disorder Diagnostics Market?
Major companies operating in the autism spectrum disorder diagnostics market are F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Siemens Healthineers, Quest Diagnostics Incorporated, Agilent Technologies Inc., Otsuka Pharmaceutical Co. Ltd., ARUP Laboratories, Invitae Corporation, Ambry Genetics, Cortica Inc., GeneDx, Cognoa Inc., Axial Therapeutics Inc., Curemark, EarliTec Diagnostics Inc., Yamo Pharmaceuticals
Which Factors Are Driving Demand in the Autism Spectrum Disorder Diagnostics Industry?
The expansion of specific diagnostic facilities is anticipated to spur the progression of the autism spectrum disorders diagnostic market. An autism-focused diagnostic center encompasses healthcare practitioners, psychologists, and specialists, carrying out extensive examinations and evaluations to diagnose the autism spectrum disorder. The surge in these specialized diagnostic centers is attributed to diagnostic improvements, the need for all-encompassing care, professional education, research, and autism recognition as a public health concern. These centers play a crucial role by improving diagnoses precision, enabling early interventions, and improving the results for individuals with ASD, through specialized expertise, sophisticated diagnostic instruments, comprehensive evaluations, personalized treatment strategies, family assistance, and research collaboration opportunities. For example, as per Autism Speaks, a non-profit autism awareness organization based in the US, the number of autism care network sites in North America rose from 20 to 25 during 2021-2022. Therefore, the rise in specific diagnostic facilities is propelling the growth of the autism spectrum disorders diagnostic market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=16593&type=smp
How Is the Autism Spectrum Disorder Diagnostics Market Segmented by Several Divisions?
The autism spectrum disorder diagnostics market covered in this report is segmented –
1) By Type: Autistic Disorder, Asperger Syndrome, Pervasive Development Disorder (PDD), Other Types
2) By Service: Behavioral Approaches, Early Intervention, Medication, Other Services
3) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Autistic Disorder: Classic Autism, Severe Autism, Mild Autism
2) By Asperger Syndrome: High Functioning Asperger Syndrome, Low Functioning Asperger Syndrome
3) By Pervasive Developmental Disorder (PDD): PDD-NOS, Childhood Disintegrative Disorder: Rett Syndrome
4) By Other Types: Childhood Autism Spectrum Disorder, Atypical Autism, Other Related Developmental Disorders
What are the Emerging Market Trends Driving the Growth of the Autism Spectrum Disorder Diagnostics Industry?
In an effort to gain a competitive advantage in the autism spectrum disorder diagnostics market, major companies are developing innovative solutions like devices that rely on Dynamic Quantification of Social-Visual Engagement (DQSVE) to capture and analyze a child’s looking behavior on a constant basis up to 120 times per second. For example, in September 2023, the Marcus Autism Center, a nonprofit healthcare and research organization in the US, launched EarliPoint™ Evaluation. This groundbreaking, FDA-approved device is developed for the early detection of autism spectrum disorder (ASD) in children from 16 to 30 months old. The novel instrument leverages eye-tracking technology to evaluate children’s social behaviors, significantly cutting down the diagnostic time from hours to only about 12 minutes.
Access The Full Report Here:
Which Regions Are Driving Growth in the Autism Spectrum Disorder Diagnostics Market?
Asia-Pacific was the largest region in the autism spectrum disorder diagnostics market in 2024. The regions covered in the autism spectrum disorder diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16593
This Report Delivers Insight On:
1. How big is the autism spectrum disorder diagnostics market, and how is it changing globally?
2. Who are the major companies in the autism spectrum disorder diagnostics market, and how are they performing?
3. What are the key opportunities and risks in the autism spectrum disorder diagnostics market right now?
4. Which products or customer segments are growing the most in the autism spectrum disorder diagnostics market?
5. What factors are helping or slowing down the growth of the autism spectrum disorder diagnostics market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
